Literature DB >> 10713888

Phenotypic variation and genetic heterogeneity in Léri-Weill syndrome.

S Schiller1, S Spranger, B Schechinger, M Fukami, S Merker, S L Drop, J Tröger, H Knoblauch, J Kunze, J Seidel, G A Rappold.   

Abstract

Léri-Weill syndrome (LWS) or dyschondrosteosis represents a short stature syndrome characterised by the mesomelic shortening of the forearms and lower legs and by bilateral Madelung deformity of the wrists. Recently, mutations in the pseudoautosomal homeobox gene SHOX have been shown to be causative for this disorder. This gene has previously been described as the short stature gene implicated in Turner syndrome (TS). We studied 32 Léri-Weill patients from 18 different German and Dutch families and present clinical, radiological and molecular data. Phenotypic inter- and intrafamilial heterogeneity is a frequent finding in LWS, and phenotypic manifestations are generally more severe in females. In males, muscular hypertrophy is a frequent finding. To test for SHOX mutations we used FISH, Southern blot and SSCP analysis as well as long-range PCR and sequencing. We identified (sub)microscopic deletions encompassing the SHOX gene region in 10 out of 18 families investigated. Deletion sizes varied between 100 kb and 9 Mb and did not correlate with the severity of the phenotype. We did not detect SHOX mutations in almost half (41%) the LWS families studied, which suggests different genetic etiologies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10713888     DOI: 10.1038/sj.ejhg.5200402

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  26 in total

Review 1.  SHOX gene in Leri-Weill syndrome and in idiopathic short stature.

Authors:  S Bernasconi; S Mariani; C Falcinelli; S Milioli; L Iughetti; A Forabosco
Journal:  J Endocrinol Invest       Date:  2001-10       Impact factor: 4.256

2.  Preimplantation genetic diagnosis (PGD) for SHOX-related haploinsufficiency in conjunction with trisomy 21 detection by molecular analysis.

Authors:  Gheona Altarescu; Orit Reish; Paul Renbaum; Ester Kasterstein; Dvorah Komarovsky; Alisa Komsky; Orna Bern; Dvorah Strassburger; Ephrat Levy-Lahad; Raphael Ron-El
Journal:  J Assist Reprod Genet       Date:  2010-12-01       Impact factor: 3.412

3.  A second recombination hotspot associated with SHOX deletions.

Authors:  Andrew R Zinn; Purita Ramos; Judith L Ross
Journal:  Am J Hum Genet       Date:  2006-03       Impact factor: 11.025

4.  Safety Outcomes and Near-Adult Height Gain of Growth Hormone-Treated Children with SHOX Deficiency: Data from an Observational Study and a Clinical Trial.

Authors:  Imane Benabbad; Myriam Rosilio; Christopher J Child; Jean-Claude Carel; Judith L Ross; Cheri L Deal; Stenvert L S Drop; Alan G Zimmermann; Nan Jia; Charmian A Quigley; Werner F Blum
Journal:  Horm Res Paediatr       Date:  2016-12-22       Impact factor: 2.852

5.  A novel class of Pseudoautosomal region 1 deletions downstream of SHOX is associated with Leri-Weill dyschondrosteosis.

Authors:  Sara Benito-Sanz; N Simon Thomas; Céline Huber; Celine Huber; Darya Gorbenko del Blanco; Darya Gorbenko Del Blanco; Miriam Aza-Carmona; John A Crolla; Vivienne Maloney; Gudrun Rappold; Jesús Argente; Jesus Argente; Angel Campos-Barros; Valérie Cormier-Daire; Valerie Cormier-Daire; Karen E Heath
Journal:  Am J Hum Genet       Date:  2005-08-15       Impact factor: 11.025

6.  Enhancer elements upstream of the SHOX gene are active in the developing limb.

Authors:  Claudia Durand; Fiona Bangs; Jason Signolet; Eva Decker; Cheryll Tickle; Gudrun Rappold
Journal:  Eur J Hum Genet       Date:  2009-12-09       Impact factor: 4.246

Review 7.  SHOX haploinsufficiency and overdosage: impact of gonadal function status.

Authors:  T Ogata; N Matsuo; G Nishimura
Journal:  J Med Genet       Date:  2001-01       Impact factor: 6.318

8.  The Human Pseudoautosomal Region (PAR): Origin, Function and Future.

Authors:  A Helena Mangs; Brian J Morris
Journal:  Curr Genomics       Date:  2007-04       Impact factor: 2.236

9.  Wrist anomalies in Turner syndrome compared with Leri-Weill dyschondrosteosis: a new feature in Turner syndrome.

Authors:  Maithé Tauber; Nadia Lounis; Julien Coulet; Christiane Baunin; Jean-Philippe Cahuzac; Pierre Rochiccioli
Journal:  Eur J Pediatr       Date:  2004-06-09       Impact factor: 3.183

10.  Effectiveness of the combined recombinant human growth hormone and gonadotropin-releasing hormone analog therapy in pubertal patients with short stature due to SHOX deficiency.

Authors:  Renata C Scalco; Suzana S J Melo; Patricia N Pugliese-Pires; Mariana F A Funari; Mirian Y Nishi; Ivo J P Arnhold; Berenice B Mendonca; Alexander A L Jorge
Journal:  J Clin Endocrinol Metab       Date:  2009-11-19       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.